Ane Gerda Zahl Eriksson, Head of the endometrial cancer and gynecologic sarcoma team at the Radium Hospital, shared a post by Live Fagereng, Project lead of Precision Diagnostic in the joint action EUnetCCC and Project Manager of the EU-project PRIME-ROSE, on LinkedIn, adding:
“For anyone interested in precision cancer diagnostics – don’t miss this opportunity to learn from leading European experts! ”
Quoting Live Fagereng‘s post:
“I’m counting down the days to Monday!
1 December i have the privilege of chairing the first onsite Educational Seminar brought to you by the Precision Cancer Diagnostics Network within EUnetCCC – European Network of Comprehensive Cancer Centers (you can also participate online) The topic is Molecular Tumor Board Operations and the seminar is completely FREE. And the speaker line-up? Pure European excellence!
Still plenty of spots – onsite in beautiful Barcelona or virtual! Register here.
Day 1 Highlights:
- Albrecht Stenzinger (University Hospital Heidelberg (UKHD) – one of Europe’s most influential molecular pathologists – on Biomarkers and Detection Methods
- Arnaud Bayle (Gustave Roussy, France) – a leading medical oncologist – on Molecular Tumor Boards operations.
- Luigide Petris (Karolinska University Hospital, Sweden) – a key member of the molecular tumor board at Karolinska – on the ethical considerations.
- Stefan Fröhling (DKFZ German Cancer Research Center, Germany) – Director of the NCT Molecular Precision Oncology Program, one of Europe’s largest and most advanced precision medicine initiatives – on multi-layered molecular profiling.
- Ana Vivancos Prellezo (Vall d’Hebron Institute of Oncology (VHIO), Spain) – Principal Investigator of VHIO’s Cancer Genomics Group – on data quality control.
- Klaus Pantel (Universitätsklinikum Hamburg Eppendorf, Germany) – The king of liquid biopsy – sharing the roadmap for implementation of liquid biopsy.
- Paul Roepman (Hartwig Medical Foundation, Netherlands) – Product Manager in one of Europe’s best molecular profiling platforms – on the role of molecular biologists.
- Loic Verlingue (Centre Léon Bérard, France) – key oncologist – on the role of oncologist.
- Tonje Gulbrandsen Lien (Oslo University Hospital, Norway) – key bioinformatics in Norway’s national precision diagnostics infrastructure – on the role of the bioinformatician
- Andrea Botticelli (Sapienza University of Rome, Italy) – key oncologist in the ROME trial – on the role of the oncologist.
- Åsmund Flobak (St. Olavs hospital, Trondheim University Hospital, Norway) – oncologist and system biologist – on the role of the oncologist.
- Erika Toth (National Institute of Oncology, Hungary) – driving force behind Hungary’s excellent national genomic profiling program – on the importance of Sample Preparation.
Massive thank you to Divya Sri Priyanka Tallapragada, PhD for brilliant organization, to Vall d’Hebron Institute of Oncology (VHIO) for opening their doors so generously, and to the entire Precision Cancer Diagnostics Network.
Let’s kick off the Holiday season by advancing precision cancer diagnostics together.”
More from Ane Gerda Zahl Eriksson on OncoDaily.
